Document is current
Any future updates will be listed below
-
Authors
Savic, Spasenija
Berezowska, Sabina
Eppenberger-Castori, Serenella
Cathomas, Gieri
Diebold, Joachim
Fleischmann, Achim
Jochum, Wolfram
Komminoth, Paul
McKee, Thomas
Letovanec, Igor
Jasarevic, Zerina
Rössle, Matthias
Singer, Gad
von Gunten, Michael
Zettl, Andreas
Zweifel, Roland
Soltermann, Alex
Bubendorf, Lukas
-
Funding
Funding for this research was provided by:
Merck Sharp and Dohme
- License Information
-
More Information
Article History
Received: 1 November 2018
Revised: 12 April 2019
Accepted: 7 May 2019
First Online: 24 May 2019
Compliance with ethical standards
:
: Spasenija Savic attended advisory board meetings of MSD and Astra Zeneca, has a consulting role for MSD, and received speaker’s honoraria from MSD and Roche.Lukas Bubendorf attended advisory board meetings of Roche, MSD, Bristol-Myers Squibb and Astra Zeneca, and received financial research support from Roche and MSD. Sabina Berezowska and Joachim Diebold received consultancy honoraria from MSD. All remaining authors have declared no conflicts of interest.
